Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Interim Management Statement

13 Jul 2010 10:36

RNS Number : 2561P
Maven Income & Growth VCT PLC
13 July 2010
 



 

Maven Income and Growth VCT PLC (the Company)

 

Interim Management Statement - quarter ended 31 May 2010

 

This Interim Management Statement, for the quarter ended 31 May 2010 is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 June 2010 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

·; Net Asset Value (NAV)* of 61.7p per share at 31 May 2010 compared to 62.3p per share at 28 February 2010; and

·; Final dividend of 3.0p per share in respect of the year ended 28 February 2010, approved by Shareholders at the Annual General Meeting for payment on 23 July 2010.

 

\* The NAV is unaudited and reflects the closing bid price of quoted securities at 31 May 2010. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 28 February 2010, adjusted for subsequent events where appropriate.

 

2.

Investments and disposals

 

During the quarter ended 31 May 2010, investments totalling £878,000 were made in five unlisted companies.

 

During the same period, a combination of partial and complete disposals of one unlisted investment and three AIM quoted investments generated aggregate proceeds of £842,000 against cost of £681,000.

 

3.

Recent developments

 

Between 1 June 2010 and the date of this statement, a total of £456,000 was invested in two unlisted companies. During the same post quarter-end period, £76,000 of loan stock was redeemed at par by an unlisted company, deferred consideration of £15,000 was received from the previous disposal of an unlisted investment; disposals of two AIM quoted investments generated aggregate proceeds of £23,000 against cost of £45,000; and £1,200,000 of UK treasury stock was redeemed at par.

 

With effect from the close of the Annual General Meeting held on 8 July 2010, and in accordance with the statement made in the Annual Report for the year ended 28 February 2010, John Pocock has replaced Fiona Wollocombe as Chairman of the Company; Mrs Wollocombe will remain a Director until the conclusion of the year ending 28 February 2011.

 

Other than described above and changes in the value of investments quoted on regulated markets, the Board is not aware of any material events during the period from 1 March to 31 May 2010, or in the period from 1 June 2010 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

13 July 2010

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUAWMUPUUBW
Date   Source Headline
6th Apr 202112:50 pmRNSDirector/PDMR Shareholding
6th Apr 20217:00 amRNSIssue of Equity
24th Mar 20215:56 pmRNSStatement re Offer for Subscription
23rd Mar 20213:41 pmRNSPublication of Suppl.Prospcts
3rd Mar 20217:05 amRNSDirector/PDMR Shareholding
3rd Mar 20217:00 amRNSIssue of Equity
8th Feb 20219:56 amRNSStatement re Offer for Subscription
4th Feb 20215:10 pmRNSTransaction in Own Shares
29th Jan 20214:42 pmRNSTransaction in Own Shares
28th Jan 20214:40 pmRNSStatement re Offer for Subscription
22nd Jan 20213:13 pmRNSNet Asset Value(s)
27th Nov 202010:41 amRNSResult of General Meeting
20th Nov 20205:18 pmRNSIssue of Equity
16th Nov 20204:53 pmRNSTransaction in Own Shares
13th Nov 20203:43 pmRNSStatement re Dividend Investment Scheme
26th Oct 20207:00 amRNSPublication of a Prospectus
19th Oct 20204:43 pmRNSHalf-year Report
15th Oct 20204:45 pmRNSStatement re NAV and Interim Dividend
26th Aug 20205:19 pmRNSTransaction in Own Shares
29th Jul 20204:42 pmRNSTransaction in Own Shares
28th Jul 20204:48 pmRNSTransaction in Own Shares
22nd Jul 20203:12 pmRNSNet Asset Value(s)
22nd Jul 20202:25 pmRNSStatement re Intended Joint Offersfor Subscription
22nd Jul 202012:18 pmRNSResult of AGM
29th May 202011:37 amRNSAnnual Financial Report
26th May 20204:54 pmRNSTransaction in Own Shares
27th Apr 20204:19 pmRNSTransaction in Own Shares
21st Apr 20205:17 pmRNSNet Asset Value & Final Dividend
26th Mar 20205:25 pmRNSUpdate on Net Asset Value
26th Mar 20205:00 pmRNSSuspension of Dividend Investment Scheme
19th Mar 20201:48 pmRNSDirector Declaration
23rd Jan 20203:36 pmRNSNet Asset Value(s)
4th Dec 20199:45 amRNSStatement re Share Premium Account Cancellation
28th Nov 20195:06 pmRNSTransaction in Own Shares
22nd Nov 20193:31 pmRNSDirector/PDMR Shareholding
22nd Nov 20192:45 pmRNSIssue of Equity
20th Nov 20194:44 pmRNSStatement re Dividend Investment Scheme
31st Oct 20194:42 pmRNSHalf-year Report
15th Oct 20192:33 pmRNSTransaction in Own Shares
15th Oct 20199:56 amRNSStatement re Net Asset Value and Interim Dividend
31st Jul 20193:37 pmRNSTransaction in Own Shares
4th Jul 20191:08 pmRNSNet Asset Value(s)
4th Jul 201912:55 pmRNSResult of AGM
24th May 20193:09 pmRNSAnnual Financial Report
20th May 20194:34 pmRNSTransaction in Own Shares
20th May 201911:29 amRNSTransaction in Own Shares
24th Apr 20199:47 amRNSIssue of Equity
5th Apr 20194:42 pmRNSHolding(s) in Company
8th Mar 20192:30 pmRNSDirector/PDMR Shareholding
8th Mar 20192:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.